These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7706182)

  • 21. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
    Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G
    J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
    Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
    Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activity of ciprofloxacin in vitro].
    Persival' A
    Antibiot Khimioter; 1993; 38(2-3):15-7. PubMed ID: 8074556
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
    Zeiler HJ; Petersen U; Gau W; Ploschke HJ
    Arzneimittelforschung; 1987 Feb; 37(2):131-4. PubMed ID: 3555512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of ofloxacin and ciprofloxacin against Mycobacterium tuberculosis strains].
    Aysev AD
    Mikrobiyol Bul; 1993 Jan; 27(1):31-5. PubMed ID: 8421440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activity of ciprofloxacin administered intravenously in a pharmacodynamic in vitro model.
    Esposito S; Jansen A
    Int J Clin Pharmacol Res; 1991; 11(4):193-9. PubMed ID: 1813438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
    Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H
    Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865
    [No Abstract]   [Full Text] [Related]  

  • 28. In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin.
    Cohen MA; Huband MD; Gage JW; Yoder SL; Roland GE; Gracheck SJ
    J Antimicrob Chemother; 1997 Aug; 40(2):205-11. PubMed ID: 9301985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
    Gao Y; Na LX; Xu Z; Zhang S; Wang AP; Lü K; Guo HY; Liu ML
    Chem Biodivers; 2018 Oct; 15(10):e1800261. PubMed ID: 29987907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of an optimized ciprofloxacin-loaded chitosan nanomicelle with enhanced antibacterial activity.
    Farhangi M; Kobarfard F; Mahboubi A; Vatanara A; Mortazavi SA
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1273-1284. PubMed ID: 29452500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.
    Vila J; Sánchez-Céspedes J; Sierra JM; Piqueras M; Nicolás E; Freixas J; Giralt E
    Int J Antimicrob Agents; 2006 Jul; 28(1):19-24. PubMed ID: 16781123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.
    Xu Z; Zhang S; Feng LS; Li XN; Huang GC; Chai Y; Lv ZS; Guo HY; Liu ML
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28703766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluation of synergistic activity between ciprofloxacin and broad snouted caiman serum against Escherichia coli.
    Siroski PA; Russi NB; Ortega HH; Formentini EA
    Res Vet Sci; 2015 Feb; 98():98-105. PubMed ID: 25468795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of ciprofloxacin against gram-positive cocci.
    Barry AL; Jones RN
    Am J Med; 1987 Apr; 82(4A):27-32. PubMed ID: 3578323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
    Qadri SM; Ueno Y; Ayub A
    Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E; Galiński J; Szponar M; Piechowicz L
    Med Dosw Mikrobiol; 1995; 47(1-2):5-9. PubMed ID: 8523970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone.
    Aoyama H; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():99-114. PubMed ID: 2849604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study on growth kinetics of organisms causing purulent infections in the presence of ofloxacin and ciprofloxacin].
    Skala LZ
    Antibiot Khimioter; 1991 Nov; 36(11):21-4. PubMed ID: 1793289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.